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Background: The aim of this study was to investigate the relationship between
intravascular ultrasound (IVUS) findings and the no-reflow phenomenon and long-term
outcome after percutaneous coronary intervention (PCI) of saphenous vein graft (SVG)
lesions.
Methods: No-reflow was defined as post-PCI TIMI grade 0, 1, or 2 flow.
Results: Of 311 patients who underwent pre- and post-stenting IVUS, no-reflow was
observed in 39 patients (13%). Degenerated SVG (62% vs. 36%, p0.002) was observed
more frequently in the no-reflow group. IVUS-detected intraluminal mass (82% vs. 43%,
p0.001), culprit lesion multiple plaque ruptures (23% vs. 6%, p0.001), and tissue
prolapse (51% vs. 35%, p0.043) were significantly more common in patients with
no-reflow. In the multivariate logistic regression analysis, an intraluminal mass (Odds
ratio [OR]4.84; 95% CI 1.98-10.49, p0.001), culprit lesion multiple plaque ruptures
(OR3.46; 95% CI 1.46-8.41, p0.014), and degenerated SVGs (OR3.17; 95% CI
1.17-6.56, p0.024) were the independent predictors of post-PCI no-reflow. At 5-year
clinical follow-up, the rates of death [14 (36%) vs. 55 (20%), p0.036] and myocardial
infarction [13 (33%) vs. 52 (19%), p0.039] were significantly higher in the no-reflow
group. However, the rate of target vessel revascularization was not different significantly
between two groups [15 (38%) vs. 90 (33%), p0.3].
Conclusions: IVUS-detected intraluminal mass, multiple plaque ruptures, and degener-
ated SVGs are associated with post-PCI no-reflow in SVG lesions. No-reflow was
associated with poor long-term clinical outcomes after PCI for SVG lesions.
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Stent Thrombosis After Intravascular Ultrasound-guided Stent Implantation
Yoshihide Fujimoto1, Masashi Yamamoto2, Yoshio Kobayashi1
1Chiba University Graduate School of Medicine, Chiba, Japan, 2Kimitsu Central
Hospital, Kisarazu, Japan
Background: Intravascular ultrasound (IVUS) is used frequently for percutaneous
coronary intervention (PCI) in Japan. However, there is little information about the
incidence of stent thrombosis after IVUS-guided stent implantation.
Methods: Between January 2005 and December 2011, 2,992 lesions in 2,685 patients
underwent IVUS-guided bare metal stent (BMS) (n981) and drug-eluting stent (DES)
implantation (n2,011). The Academic Research Consortium definition of stent throm-
bosis was used.
Results: Definite stent thrombosis was observed in 10 lesions (1.0%) with BMS (early
0.9%, late 0.1%, and very late 0%) and 9 lesions (0.4%) with DES (early 0.2%, late 0%,
and very late 0.2%). Stent thrombosis occurred in 12 (1.6%) and 7 lesions (0.4%) that had
undergone PCI for acute myocardial infarction and other indications, respectively. Stent
underexpansion was observed in 6 (46%) of the 13 lesions with early stent thrombosis. On
the other hand, none of the 6 lesions with late or very late stent thrombosis had stent
underexpansion.
Conclusions: IVUS-guided stent implantation results in a low incidence of stent
thrombosis. Stent underexpansion is a risk factor of early stent thrombosis, but it was not
for late or very late stent thrombosis.
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Background: Little is known about the role of macrophage accumulations (M) on
bare-metal stent (BMS) failure.
Methods: We evaluated 43 consecutive BMS failure lesions in 43 patients (11 acute
coronary syndrome [ACS] and 32 stable myocardial ischemia [SMI], median stent
duration 9.6 [interquartile range 6.9-58.8] months) by optical coherence tomography.
Neointima with Mwas defined as thin bright layer with shadowing (peak intensity180
and attenuation rate 2, when measurements were fitted to an approximate exponential
function).
Results: The mean age was 67.410.0 years, 40 patients (93.0%) were male, and 16
(37.2%) were diabetic. Compared with SMI patients, ACS patients showed higher
incidence of thin-cap fibroatheroma (TCFA)-containing neointima (63.6% versus 6.3%,
p0.0003), lesions with M (72.7% versus 9.4%, p0.0001), neointimal rupture (72.7%
versus 15.6%, p0.001), thrombus (81.8% versus 43.8%, p0.039), and had higher
admission LDL (116.426.6 versus 90.823.9 mg/dl, p0.012) and lower HDL
cholesterol level (39 [range 33-45] versus 47 [40-55] mg/dl, p0.021). Stent failure with
TCFA-containing neointima (n9) expressed higher incidence of M (88.9% versus
8.8%, p0.0001), larger M angle (143 [range 84-262] versus 0 [0-0] °, p0.002), and
longer M longitudinal length (8 [range 5-13] versus 0 [0-0] mm, p0.003) than
non–TCFA-containing neointima (n34). Fibrous cap thickness negatively correlated
with M longitudinal length (r–0.00449, p0.045). Compared with lesions without
neointimal rupture (n30), lesions with neointimal rupture (n13) demonstrated higher
incidence of M (69.2% versus 6.7%, p0.0001). Thrombotic stent failure lesions
(n23) showed more M (39.1% versus 10.0%, p0.039) than non-thrombotic lesions
(n20). Eleven stent failure patients with M presented later than 32 patients without
M: 104.8 (range 58.8-142.4) versus 9.0 (6.6-13.3) months (p0.0004). Using receiver-
operating curve analysis, 16.7 months was the best predictor of the presence of M with
a sensitivity of 100% and a specificity of 84% (area under curve 0.960, p0.0001).
Conclusions: M might be associated with neoatherosclerosis and unstable features of
BMS neointima.
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Background: Recent studies have demonstrated that peri-strut low intensity area (PLIA)
seen on optical coherence tomography (OCT) represents neointimal fibrinogen and/or
extracellular matrix and is associated with neointimal thickening (NIT) after 1st-
generation drug-eluting stents (DES) implantation. However, there are no data regarding
PLIA in new generation DES and its change in serial OCT evaluations.
Methods: A total of 83 patients underwent 9-month OCT after DES implantation (25
sirolimus-eluting stents [SES], 20 paclitaxel-eluting stents [PES], 30 zotarolimus-eluting
stents [ZES], and 8 everolimus-eluting stents [ZES]). PLIA on OCT was defined as a
region around stent struts with homogenous lower intensity than surrounding tissue
without signal attenuation. Inter-stent analysis was performed between PLIA	 and PLIA
– stents, and then intra-stent analysis was performed between PLIA 	 and overall stent
segments. The patients also underwent 2-year OCT evaluations and serial change of NIT
was analyzed.
Results: The incidence of PLIA 	 stents on 9-month OCT was highest in PES and
lowest in SES (90% in PES vs. 28% in SES vs. 60% in ZES vs. 63% in EES, p0.001).
In inter-stent analysis, PLIA	 stents showed higher mean NIT than PLIA – stents (20.11
 9.69 m vs. 10.86  5.46 m, p 0.001). Also in intra-stent analysis, PLIA 	
segments showed higher mean NIT than overall stent segments (25.79  12.22 m vs.
20.11  9.69 m, p  0.013). On serial 2-year OCT, PLIA 	 stents showed smaller
increase of NIT than PLIA – stents in inter-stent analysis (3.46  10.50 m vs. 7.41 
10.07 m, p  0.092). Also in intra-stent analysis, PLIA 	 segments showed smaller
increase of NIT than overall stent segments (1.76  11.63 m vs. 3.46  10.50 m, p
 0.451). All of these findings were regardless of DES type.
Conclusions: Although PLIA was associated with increased NIT regardless of DES type,
it may mean weak potential for further neointimal growth in long-term follow-up.
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Relationship Between Arterial Remodeling, Fibrous Cap Thinning and Lipid
Accumulation: A Serial Integrated Backscatter Intravascular Ultrasound and
Optical Coherence Tomography Study
Teruyoshi Kume1, Hiroyuki Okura1, Kenzo Fukuhara1, Yoshinori Miyamoto1,
Shintaro Nezuo1, Yoji Neishi1, Akihiro Hayashida1, Takahiro Kawamoto1,
Kiyoshi Yoshida1
1Kawasaki medical school, Kurashiki City, Japan
Background: A serial intravascular ultrasound (IVUS) and optical coherence tomogra-
phy (OCT) study has shown that positive arterial remodeling was related to thinning of
fibrous cap. Serial changes in tissue components associated with fibrous cap and/or arterial
remodeling is unknown Therefore, the purpose of this study was to evaluate the
relationship between changes in fibrous cap thickness and changes in plaque tissue
components by using optical coherence tomography (OCT) and integrated backscatter
IVUS (IB-IVUS).
Methods: Serial (baseline and 6 months follow-up) IB-IVUS and OCT examinations
were performed on 81 vessels from 56 patients with ischemic heart disease who
underwent percutaneous coronary intervention. 81 fibroatheromas were selected from 48
culprit lesions and 33 non-culprit lesions. Serial changes and relationships between
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IB-IVUS derived tissue components (calcification, dense fibrosis, fibrosis, lipid pool) and
fibrous cap thickness were investigated.
Results: The percent changes in fibrous cap thickness correlated negatively and
significantly with the percent changes in external elastic membrane cross sectional area
(r-0.5, P0.0001). The %changes in fibrous cap thickness correlated negatively and
significantly with %changes in lipid pool area (r-0.61, P0.0001). The %changes in
fibrous cap thickness correlated positively with calcification, dense fibrosis or fibrosis, as
well (r0.44, P0.0001, r0.60, P0.0001, and r0.54, P0.0001, respectively).
Conclusions: Arterial remodeling with changes in lipid pool component is related to
changes in fibrous cap thickness. Positive arterial remodeling with lipid accumulation may
represent an unstable or vulnerable process of the coronary arterial plaque.
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Background: Statin theraphy have been shown the regression of coronary artery plaque.
However a few data was reported about the change of left main coronary artery.
Methods: We used Virtual Histology Intravascular Ultrasound (VH-IVUS) to assess
mild to moderate left main coronary artery (LMCA) disease in 500 consecutive pts and
identified 50 pts with who had serial VH-IVUS examinations at baseline and at follow-up
at 12 months. VH-TCFA (thin-capped fibroatheroma) was defined as necrotic core (NC)
10% of plaque area with a plaque burden of 40% and NC in contact with the lumen
for 3 image slices. Positive remodeling was a remodeling index (lesion/reference EEM
[external elastic membrane] area) 1.05.
Results: Pt age was 5713 yrs and 20% were diabetics. The incidence of LM-TCFA was
11.2% (56/500). following 16 pts with VH-TCFA at baseline and serial VH-IVUS, distal
reference lumen area was 14.64.2 mm2. LMCA length was 6.44.0mm, and the rate of
positive remodeling was 14% (8/56). 74% of VH-TCFA were located in mid-body of the
LMCA and the rest at the distal bifurcation. After 12 months of statin therapy, minimal
lumen area (12.83.8 to 12.44.5 mm2, p0.6) and maximum %NC (28.013.2 to
27.212.1, p0.8) were similar; and only 37.5% (6/16) of VH-TCFA had healed to a
non-VH-TCFA phenotype and 3 new VH-TCFA appeared (Table) even though low
density lipoprotein (LDL) level was decreased in 87.5 % (14/16) pts with 12/16 having an
LDL 100mg/dL.
Conclusions: Healing of VH-TCFA in the LMCA is not high during “routine” statin
therapy. This suggests the need for more strict control of risk factors in these pts.
Follow-up
Baseline
PIT
(n14)
ThCFA
(n5)
TCFA
(n13)
Fibrotic
(n12)
Fibrocalcific
(n6)
PIT (n14) 14
ThCFA (n1) 1
TCFA (n16) 1 10 3 2
Fibrotic (n15) 3 3 9
Fibrocalcific (n4) 4
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Culprit lesion phenotype may depend on lesion location in patients with ST
elevation acute myocardial infarction: TAMI-R study
Sang-Wook Kim1, Wang-Soo Lee1, Gary Mintz2, JeeEun Kwon1, EunYoung Kim1,
KwangJe Lee1, CheeJeong Kim1, TaeHo Kim1, Neil Weissman3
1Chung-Ang University Hospital, Seoul, Korea, Republic of, 2CRF, washington,
United States, 3MedStar Washington Hosp Center, Washington, USA
Background: Thin capped fibroatheroma(TCFA) is a principal pathophysiologic mech-
anism to occur acute coronary syndrome. However, the characteristics of each TCFA have
not been evaluated.
Methods: We used virtual histology-intravascular ultrasound (VH-IVUS) to assess
culprit lesions in 196 consecutive pts with ST elevation acute myocardial infarction
(STEMI) and compared culprit lesions in the RCA (59 pts) with culprit lesions in the left
coronary artery (LCA, 137 pts). VH-thin-capped fibroatheromas (VH-TCFAs) were
defined as necrotic core (NC) 10% of plaque area, plaque burden 40%, and NC in
contact with the lumen for 3 image slices.
Results: Plaque ruptures were seen in 85/196 of which 52 were located in the proximal
30mm of a coronary artery. Lesion length was similar; vessel size, plaque burden,
minimal lumen area, and average %NC were larger; and VH-TCFA phenotype was more
common (60% vs 31%, p0.001) in RCA vs LCA-STEMI (Table). Importantly, culprit
lesion plaque ruptures were more common in RCA (45.5%) vs LAD-STEMI (30.1%,
p0.034) as was the frequency of VH-TCFA phenotype in the setting of culprit plaque
ruptures (72% in RCA vs 29% in LAD-STEMI, p0.005).
Conclusions: Plaque ruptures are not always detected by IVUS in culprit lesions of pts
presenting with STEMI, and VH-TCFA phenotype is not always seen in these culprit
lesions whether or not plaque rupture is detected. Rather, plaque rupture and VH-TCFA
phenotype in culprit lesions of STEMI pts appear to depend on location (RCA vs LCA)
and vessel size.
RCA LCA p-value
Lesion length (mm) 20.60	/7.81 23.39	/10.29 0.200
Distal reference lumen
area (mm2)
9.06	/4.05 6.84	/3.32 0.002
Minimal lumen area
(mm2)
4.52	/2.58 3.49	/1.85 0.007
Vessel area (mm2)
(ruptured site)
21.00	/6.00 16.83	/5.09 0.004
Lumen area (mm2)
(ruptured site)
7.59	/2.81 6.05	/2.33 0.020
Plaque area (mm2)
(ruptured site)
11.31	/3.92 8.30	/3.41 0.027
Ruptured cavity (mm2) 1.18	/1.05 0.83	/0.69 0.145
Remodeling index (@
ruptured site)
1.04	/0.19 1.13	/0.29 0.193
average fibrotic plaque (%) 59.96	/10.32 58.09	/13.43 0.425
average fibrofatty plaque
(%)
10.08	/5.34 9.60	/5.57 0.606
average necrotic core (%) 20.52	/8.42 17.38	/7.73 0.020
average dense calcium (%) 8.66	/6.06 10.51	/7.01 0.118
VH-IVUS phenotype 0.02
Pathologic intimal
thickening
2 8
Thick cap fibrotheroma 0 1
VH-TCFA 22 21
Fibrotic 2 13
Fibrocalcific
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High Level of Copeptin in ST elevation Acute Myocardial Infarction patients
is associated with In-Hospital Mortality and Plaque Rupture; TAMI-COP
study
Sang-Wook Kim1, Gary Mintz2, Wang Soo Lee1, EunYoung Kim1, Jun Hwan Jo1,
KwangJe Lee1, CheeJeong Kim1, TaeHo Kim1, Neil Weissman3
1Chung-Ang University Hospital, Seoul, Korea, Republic of, 2CRF, washington,
United States, 3MedStar Washington Hosp Center, Washington, USA
Background: Copeptin has been known to predict heart failure and cardiovascular death
in patients with acute coronary syndrome.
Methods: We collected coronary arterial blood samples from the infarct artery during
primary percutaneous coronary intervention (PCI) in 80 STEMI pts and 28 controls. We
assessed commonly used cardiac biomarkers (CK, CK-MB, troponin-I, CRP) and
additionally measured recently introduced biomarkers (Copeptin [C-terminal Provaso-
pressin] and N-terminal pro-B-type natriuretic peptide [NT-proBNP]).
Results: Pt age was 5812 yrs and 93% were males. Intravascular ultrasound (IVUS) of
the culprit lesion in 80 pts showed ruptured plaques in 36 pts. STEMI pts had a higher
Copeptin level (265.89183.10 pmol/L) vs193.6760.17 pmol/L in normal controls,
p0.005. Especially, Copeptin levels were higher in ruptured plaque compared to
non-ruptured plaques: 318.83209.34 pmol/L vs 221.99151.49 pmol/L, p0.034.
While troponin I, CK-MB, and CRP were not correlated with Copeptin, NT-proBNP was
correlated with copeptin (r0.579, p0.0003). In hospital death occurred in 7 pts with a
high Copeptin level (figure); all were due to cardiogenic shock after primary PCI.
Conclusions: Copeptin levels are associated with plaque rupture in STEMI pts and
predict mortality after primary PCI.
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